This is a non-interventional, national, multi center, prospective multiple myeloma registry in Turkey
In this study, approximately from 40 centers 1000 patients will be recruited. All patients will be followed-up till the study end. All the laboratory results, treatment protocols and responses will be recorded and assessed with EORTC Multiple Myeloma Specific Quality of Life Multiple Myeloma Specific (MY-20) and EORTC Quality of Life-C30 questionnaires.
Study Type
OBSERVATIONAL
Enrollment
1,000
Medipol University
Istanbul, Turkey (Türkiye)
RECRUITINGOverall Survival
Time from the diagnosis to the death
Time frame: [Time Frame: 5 Years]
Progression Free Survival
Time from the initiation of treatment to the death from any cause or progression
Time frame: [Time Frame: 5 Years]
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.